Who is sponsoring NCT05426590?

NCT05426590 is sponsored by Marwa Ahmed.

What drugs are being tested in NCT05426590?

Interventions in NCT05426590: Specular biomicroscopy.

What condition does NCT05426590 study?

NCT05426590 studies Corneal Endothelial Changes After Phacoemulsification.

Is NCT05426590 still recruiting?

NCT05426590 is currently status unknown. Last updated 22 June 2022.

Last reviewed 2022-06-22 · How we verify

NCT05426590

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Corneal Endothelial Changes After Uneventful Phacoemulsification in Diabetic and Non-diabetic Patients in Relation to the Level of Glcosylated Hemoglobin Level

Status unknown NA Last updated 22 June 2022

What this trial tests

NA trial testing Specular biomicroscopy in Corneal Endothelial Changes After Phacoemulsification in 68 participants. Status unknown.

Timeline

20 May 2022

Primary endpoint
17 November 2022

17 November 2022

Quick facts

Lead sponsor	Marwa Ahmed
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	68
Start date	20 May 2022
Primary completion	17 November 2022
Estimated completion	17 November 2022
Sites	1 location across Egypt

Drugs / interventions tested

Specular biomicroscopy

Conditions studied

Corneal Endothelial Changes After Phacoemulsification — all drugs for Corneal Endothelial Changes After Phacoemulsification →

Sponsor

Marwa Ahmed

Who can join

Adults 50 to 70, any sex, with Corneal Endothelial Changes After Phacoemulsification. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of corneal endothelial changes after uneventful phacoemulsification in diabetic and non-diabetic patients using specular biomicroscopy in relation to the level of glcosylated hemoglobin level

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05426590 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marwa Ahmed
Last refreshed: 22 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05426590.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing